While there is no evidence for differential expression of TMEM180 in the context of leprosy, we find evidence that ACTR1A expression is down-regulated in leprosy lesions compared to the skin of healthy controls, and that it is also differentially expressed according to clinical subtype of leprosy. Here, ACTR1A is linked to leprosy.